Hypertension Diagnosis and Management in Family Practice
Today, hypertension is a frequently seen insidious disease. It attracts attention as a main reason of too many life threatening diseases. In the area of medicine, many honourable international communities are still studying on actual researches about hypertension and in the light of these data they publish periodic current treatment guidelines. It is important to follow current information and be aware of special conditions among the disease and the treatment for the doctors those managing hypertension. It is a significant art of medicine to select the medicine for the characteristics of the patient and to rearrange it for some special conditions while follow up. Family physicians have a great responsibility in the management of hypertension which effects significant number of people in the community. In this article, latest actual information about hypertension, which is a necessity for the doctors those managing hypertension, is gathered together in the light of current guidelines.
- 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536.
- Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
- Guilbert JJ. The world health report 2002-reducing risks, promoting healthy life. Educ Health (Abingdon). 2003;16:230.
- Nesbitt SD, Julius S, Leonard D, Egan BM, Grozinski M. Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study. Am J Hypertens 2005;18:980-985.
- Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA 2005;294:2330-2335.
- Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297:319-328.
- Brown MJ. Hypertension and ethnic group. BMJ 2006;332:833-836.
- Williams B, Poulter NR, Brown MJ et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-185.
- Dahlof B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.
- Jamerson K, Weber MA, Bakris GL et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417- 2428.
- Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-1559.